Biofilm-coated microbeads and the mouse ear skin: An innovative model for analysing anti-biofilm immune response in vivo.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 19 08 2020
accepted: 20 11 2020
entrez: 4 12 2020
pubmed: 5 12 2020
medline: 28 1 2021
Statut: epublish

Résumé

Owing to its ability to form biofilms, Staphylococcus aureus is responsible for an increasing number of infections on implantable medical devices. The aim of this study was to develop a mouse model using microbeads coated with S. aureus biofilm to simulate such infections and to analyse the dynamics of anti-biofilm inflammatory responses by intravital imaging. Scanning electron microscopy and flow cytometry were used in vitro to study the ability of an mCherry fluorescent strain of S. aureus to coat silica microbeads. Biofilm-coated microbeads were then inoculated intradermally into the ear tissue of LysM-EGFP transgenic mice (EGFP fluorescent immune cells). General and specific real-time inflammatory responses were studied in ear tissue by confocal microscopy at early (4-6h) and late time points (after 24h) after injection. The displacement properties of immune cells were analysed. The responses were compared with those obtained in control mice injected with only microbeads. In vitro, our protocol was capable of generating reproducible inocula of biofilm-coated microbeads verified by labelling matrix components, observing biofilm ultrastructure and confirmed in vivo and in situ with a matrix specific fluorescent probe. In vivo, a major inflammatory response was observed in the mouse ear pinna at both time points. Real-time observations of cell recruitment at injection sites showed that immune cells had difficulty in accessing biofilm bacteria and highlighted areas of direct interaction. The average speed of cells was lower in infected mice compared to control mice and in tissue areas where direct contact between immune cells and bacteria was observed, the average cell velocity and linearity were decreased in comparison to cells in areas where no bacteria were visible. This model provides an innovative way to analyse specific immune responses against biofilm infections on medical devices. It paves the way for live evaluation of the effectiveness of immunomodulatory therapies combined with antibiotics.

Identifiants

pubmed: 33275636
doi: 10.1371/journal.pone.0243500
pii: PONE-D-20-26002
pmc: PMC7717515
doi:

Substances chimiques

Fluorescent Dyes 0
Silicon Dioxide 7631-86-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0243500

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infect Immun. 2018 Jul 23;86(8):
pubmed: 29784858
Expert Rev Anti Infect Ther. 2018 Jan;16(1):51-65
pubmed: 29235402
Lett Appl Microbiol. 2010 Sep;51(3):358-61
pubmed: 20618890
Nat Protoc. 2007;2(7):1705-12
pubmed: 17641635
Cytometry A. 2018 Mar;93(3):357-370
pubmed: 28976646
Biomed Res Int. 2016;2016:4708425
pubmed: 28078291
Front Microbiol. 2017 Nov 21;8:2309
pubmed: 29209305
J Am Acad Orthop Surg. 2017 Feb;25 Suppl 1:S20-S24
pubmed: 27922945
FEBS Lett. 2020 Aug;594(16):2556-2569
pubmed: 32144756
Nat Rev Microbiol. 2018 Jul;16(7):397-409
pubmed: 29720707
BMC Microbiol. 2020 Jan 29;20(1):22
pubmed: 31996131
Int J Oral Sci. 2015 Mar 23;7(1):1-7
pubmed: 25504208
Sci Rep. 2018 Aug 29;8(1):13040
pubmed: 30158585
J Orthop Res. 2015 Sep;33(9):1311-9
pubmed: 25820925
Front Immunol. 2019 May 17;10:1082
pubmed: 31156635
J Immunol. 2011 Jun 1;186(11):6585-96
pubmed: 21525381
Front Immunol. 2018 Jan 04;8:1895
pubmed: 29354120
FEMS Microbiol Lett. 1992 Jul 1;73(1-2):133-8
pubmed: 1521761
Appl Environ Microbiol. 2004 Oct;70(10):6076-85
pubmed: 15466553
J Immunol. 2014 Apr 15;192(8):3778-92
pubmed: 24646737
Int J Cell Biol. 2012;2012:179207
pubmed: 22829830
J Chin Med Assoc. 2018 Jan;81(1):7-11
pubmed: 29042186
J Hosp Infect. 2018 Feb;98(2):111-117
pubmed: 29175074
Clin Microbiol Infect. 2013 Feb;19(2):181-6
pubmed: 22264335
Science. 2008 Aug 15;321(5891):970-4
pubmed: 18703742
Front Microbiol. 2019 Jul 17;10:1602
pubmed: 31379772
PLoS One. 2016 Jun 17;11(6):e0157663
pubmed: 27315246
Appl Environ Microbiol. 2005 May;71(5):2663-76
pubmed: 15870358
Orthopedics. 2014 Apr;37(4):257-65
pubmed: 24762833
Infect Immun. 2012 Aug;80(8):2601-7
pubmed: 22585963
mBio. 2015 Aug 25;6(4):
pubmed: 26307164
Int J Nanomedicine. 2017 Apr 28;12:3421-3432
pubmed: 28496319
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
Infect Immun. 2011 Apr;79(4):1789-96
pubmed: 21282411
Am J Pathol. 2015 Jun;185(6):1518-27
pubmed: 25749135
Environ Microbiol. 2008 Aug;10(8):2098-110
pubmed: 18430020
Int J Med Microbiol. 2019 Jan;309(1):1-12
pubmed: 30503373
J Vis Exp. 2016 May 18;(111):
pubmed: 27286053
Front Microbiol. 2018 Feb 28;9:359
pubmed: 29541068

Auteurs

Léo Sauvat (L)

Laboratoire Microorganismes: Génome et Environnement, Université Clermont Auvergne, UMR CNRS 6023, Clermont-Ferrand, France.
Infectious and Tropical Diseases Department, CRIOA, CRMVT, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Aizat Iman Abdul Hamid (AI)

Laboratoire Microorganismes: Génome et Environnement, Université Clermont Auvergne, UMR CNRS 6023, Clermont-Ferrand, France.

Christelle Blavignac (C)

Centre Imagerie Cellulaire Santé, Université Clermont Auvergne, Clermont-Ferrand, France.

Jérôme Josse (J)

CIRI-Centre International de Recherche en Infectiologie, Inserm, U1111, CNRS, UMR5308, École Normale Supérieure de Lyon, Université Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Olivier Lesens (O)

Laboratoire Microorganismes: Génome et Environnement, Université Clermont Auvergne, UMR CNRS 6023, Clermont-Ferrand, France.
Infectious and Tropical Diseases Department, CRIOA, CRMVT, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Pascale Gueirard (P)

Laboratoire Microorganismes: Génome et Environnement, Université Clermont Auvergne, UMR CNRS 6023, Clermont-Ferrand, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH